Natesto Alleviates Migraines in Hypogonadal U.S. Males: Multicenter Phase IV Trial
Reading Time: < 1 minuteIntroduction Migraines afflict millions of American males annually, with epidemiological data from the American Migraine Foundation indicating that up to 12% of men experience episodic or chronic migraines, often exacerbated by hormonal imbalances such as hypogonadism. Low serum testosterone levels, prevalent in 2-6 million U.S. men aged 40-70 per CDC estimates, have been implicated in heightened neuroinflammatory responses and central... Read more »
